Concussion Treatment in Older Adults
Completed · Not applicable
Conditions studied: Concussion, Mild
In brief
The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with the participant's second concussion clinical visit, typically (but not limited to) between 21-31 days from V1.
Key facts
- Study ID
- NCT05849064
- Run by
- University of Pittsburgh
- People needed
- 56
- Starts
- 2023-09-07
- Expected to finish
- 2026-06-15
- Last updated by the study team
- 2026-08-06
Who can join
Age: 50 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- 50 years of age or older
- Diagnosed concussion within the last 4 days - 12 months
- Must be recruited at their initial concussion appointment
- Ability to read/write to complete study assessments/testing
You may not qualify if…
- Diagnosed major psychiatric disorders other than depression/anxiety (e.g., schizophrenia)
- Diagnosed with moderate to severe brain injury or past brain surgery/malformations
Where it is running
- University of Pittsburgh — Pittsburgh, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.